NCT06380972View on ClinicalTrials.gov

A Prospective, Randomized, No-treatment Controlled, Evaluator-blinded Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Microspherical Injectable to Improve Forehead Contour

NARecruitingINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Forehead Contouring
Interventions
DEVICE

Polycaprolactone (PCL) Based Facial Injectable

Polycaprolactone (PCL) Based Facial Injectable

Trial Locations (2)

510317

NOT_YET_RECRUITING

Guangdong Second Provincial General Hospital, Guangzhou

Unknown

RECRUITING

Guangdong Second Provincial General Hospital, Guangzhou

Sponsors

Lead Sponsor

AQTIS Medical B.V.
All Listed Sponsors
lead

AQTIS Medical B.V.

OTHER

NCT06380972 - A Prospective, Randomized, No-treatment Controlled, Evaluator-blinded Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Microspherical Injectable to Improve Forehead Contour | Biotech Hunter | Biotech Hunter